Mohammad Saud Alanazi
- Medical Laboratory Technology top 10%
-
- Drug Transport and Resistance Mechanisms 3
-
- Immune Response and Inflammation 5
- Toxin Mechanisms and Immunotoxins 3
-
- Asthma and respiratory diseases 4
-
- Pharmacogenetics and Drug Metabolism 3
-
- Animal Diversity and Health Studies 3
-
- Translation Studies and Practices 3
-
- Neonatal Health and Biochemistry 2
- Co-authors
- Narasimha Reddy ParineAbdullah AlamriAbdelhabib SemlaliNahla AzzamHesham SaeedZahid KhanManal ShalabyMahmoud Rouabhia
- Partner nations
- Saudi ArabiaCanadaEgypt
In The Last Decade
Mohammad Saud Alanazi
34 papers receiving 405 citations
Peers
Comparison fields: 5 of 89
- Medical Laboratory Technology 9
- Cancer Research 78
- Oncology 87
- Oral Surgery 21
- Immunology 60
Countries citing papers authored by Mohammad Saud Alanazi
This map shows the geographic impact of Mohammad Saud Alanazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Saud Alanazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Saud Alanazi more than expected).
Fields of papers citing papers by Mohammad Saud Alanazi
This network shows the impact of papers produced by Mohammad Saud Alanazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Saud Alanazi. The network helps show where Mohammad Saud Alanazi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohammad Saud Alanazi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2022 | 0 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 19 | |
| 11 | 2018 | 19 | |
| 12 | 2018 | 21 | |
| 13 | 2017 | 4 | |
| 14 | 2017 | 8 | |
| 15 | 2016 | 7 | |
| 16 | 2016 | 52 | |
| 17 | 2014 | 2 | |
| 18 | 2014 | 5 | |
| 19 | 2011 | 1 | |
| 20 | 2010 | 6 |
About Mohammad Saud Alanazi
Mohammad Saud Alanazi is a scholar working on Medical Laboratory Technology, Family Practice and Immunology, having authored 42 papers that have together received 408 indexed citations. Recurring topics across this work include Immune Response and Inflammation (5 papers), Asthma and respiratory diseases (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Animal Diversity and Health Studies (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Translation Studies and Practices (3 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Medical Laboratory Technology (9 citations), Cancer Research (78 citations) and Oncology (87 citations). Mohammad Saud Alanazi has collaborated with scholars based in Saudi Arabia, Canada and Egypt. Frequent co-authors include Narasimha Reddy Parine, Abdullah Alamri, Abdelhabib Semlali, Nahla Azzam, Hesham Saeed, Zahid Khan, Manal Shalaby, Mahmoud Rouabhia, Abdulrahman Aljebreen and Othman Alharbi. Their work appears in journals such as PLoS ONE, OncoTargets and Therapy, Journal of Oncology, Protein Expression and Purification and The Protein Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.